Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
54.77
-2.41 (-4.21%)
At close: Apr 28, 2026, 4:00 PM EDT
55.68
+0.91 (1.66%)
After-hours: Apr 28, 2026, 7:29 PM EDT
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
148.00M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Agenus | 114.20M |
| Black Diamond Therapeutics | 70.00M |
| Spero Therapeutics | 66.80M |
| ProQR Therapeutics | 19.19M |
| Alpha Cognition | 10.22M |
| Fate Therapeutics | 6.65M |
| Alps Group | 3.74M |
| Molecular Partners AG | 856.30K |
SPRB News
- 8 days ago - Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 8 days ago - Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 7 weeks ago - Spruce Biosciences Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Spruce Biosciences Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates - Business Wire
- 7 weeks ago - Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer - Business Wire
- 2 months ago - Spruce Biosciences to Present at Upcoming Investor Conferences in March - Business Wire
- 2 months ago - Spruce Biosciences Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts